Last Modified

• March 20, 2019

Creator

• Bash, Ryan
  • Affiliation: School of Medicine, Curriculum in Genetics and Molecular Biology

Abstract

• Glioblastoma multiforme (GBM) is a devastating tumor of the central nervous system and is the most frequently occurring primary brain tumor in adults. While much progress has been made in reducing the mortality associated with other forms of cancer, morbidity from GBM remains unchanged. The lack of progress in treatment of GBM highlights the continuing need for accurate preclinical animal models as a means of understanding pathogenesis and providing a resource for testing of potential therapies. To model the development of GBM, we have developed a system using genetically engineered mouse (GEM) models in which silent mutant alleles can be converted to active oncogenes or inactive tumor supressors using the cre-lox recombination system. Through stereotactic injection of replication incompetent lentivirus expressing Cre-recombinase into the cortex of these animals, we have assessed the impact of known effectors of astrocytoma to induce and advance tumors originating from terminally differentiated astrocytes in the context of surrounding normal brain tissue.

Date of publication

• December 2010

DOI

• https://doi.org/10.17615/fsc0-x415

Resource type

• Masters Thesis

Rights statement

• In Copyright

Note

• "... in partial fulfillment of the requirements for the degree of Master of Science in the Department of Genetics and Molecular Biology, School of Medicine."

Advisor

• Van Dyke, Terry A.

Language

• English

Publisher

• University of North Carolina at Chapel Hill

Place of publication

• Chapel Hill, NC

Access

• Open access

Parents:

This work has no parents.

Items

Thumbnail	Title	Date Uploaded	Visibility	Actions
	Development and characterization of a focally induced mouse model of glioblastoma multiforme originating from terminally differentiated astrocytes	2019-04-11	Public	Press to Select an action Download